Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency
Cellyan Biotechnology Receives Nasdaq Notice
Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders
One Hong Kong Pharma Digital Technology Holdings Insider Raised Their Stake In The Previous Year
12 Industrials Stocks Moving In Friday's Intraday Session
Is Hong Kong Pharma Digital Technology Holdings Limited's (NASDAQ:HKPD) 36% ROE Better Than Average?
Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024
Hong Kong Pharma Digital Technology Holdings Financial Results For Six Months Ended September 30: Net Revenues Total $11.09M Up 58.9% YoY; Achieved Net Income Of $828,559, Up 232.6% YoY
Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering
Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
